Vaccines & Autism

Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.

    Related Conference of Vaccines & Autism

    October 24-25, 2024

    5th International Conference on Immunology And Immunotherapy

    Zurich, Switzerland
    November 26-27, 2024

    38th International Conference on Immunology

    Madrid, Spain
    June 16-17, 2025

    19th International Conference on European Immunology

    Frankfurt, Germany

    Vaccines & Autism Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in